HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2009
22601	22601 Lu YM, Ansar S, Michaelis ML, Blagg BSJ Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line BIOORGANIC & MEDICINAL CHEMISTRY. 2009 FEB 15; 17 (4): 1709-1715	1	6	6	40
22602	22602 Jacobs FMJ, van Erp S, van der Linden AJA, von Oerthel L, Burbach JPH, et al. Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression DEVELOPMENT. 2009 FEB 15; 136 (4): 531-540	2	15	5	64
22603	22603 Sato T, Miura M, Yamada M, Yoshida T, Wood JD, et al. Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice HUMAN MOLECULAR GENETICS. 2009 FEB 15; 18 (4): 723-736	1	5	10	46
22604	22604 Rohrer JD, Rossor MN, Warren JD Neologistic jargon aphasia and agraphia in primary progressive aphasia JOURNAL OF THE NEUROLOGICAL SCIENCES. 2009 FEB 15; 277 (1-2): 155-159	1	2	9	44
22605	22605 Olanow CW, Gracies JM, Goetz CG, Stoessl AJ, Freeman T, et al. Clinical Pattern and Risk Factors for Dyskinesias Following Fetal Nigral Transplantation in Parkinson's Disease: A Double Blind Video- Based Analysis MOVEMENT DISORDERS. 2009 FEB 15; 24 (3): 336-343	7	7	12	35
22606	22606 Edler J, Mollenhauer B, Heinemann U, Varges D, Werner C, et al. Movement Disturbances in the Differential Diagnosis of Creutzfeldt- Jakob Disease MOVEMENT DISORDERS. 2009 FEB 15; 24 (3): 350-356	0	4	7	34
22607	22607 Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, et al. FGF20 and Parkinson's Disease: No Evidence of Association or Pathogenicity via alpha-Synuclein Expression MOVEMENT DISORDERS. 2009 FEB 15; 24 (3): 455-459	6	6	2	16
22608	22608 Salat DH, Greve DN, Pacheco JL, Quinn BT, Helmer KG, et al. Regional white matter volume differences in nondemented aging and Alzheimer's disease NEUROIMAGE. 2009 FEB 15; 44 (4): 1247-1258	2	11	8	93
22609	22609 Brooks D, Halliday GM Intralaminar nuclei of the thalamus in Lewy body diseases BRAIN RESEARCH BULLETIN. 2009 FEB 16; 78 (2-3): 97-104	0	1	14	39
22610	22610 Kassiou M, Banati R, Holsinger RMD, Meikle S Challenges in molecular imaging of Parkinson's disease: A brief overview BRAIN RESEARCH BULLETIN. 2009 FEB 16; 78 (2-3): 105-108	1	3	10	35
#	Date / Author / Journal	LCS	GCS	LCR	CR
22611	22611 Rascol O "Disease-modification" trials in Parkinson disease: Target populations, endpoints and study design NEUROLOGY. 2009 FEB 17; 72: S51-S58	2	6	5	53
22612	22612 Chu J, Hong NA, Masuda CA, Jenkins BV, Nelms KA, et al. A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009 FEB 17; 106 (7): 2097-2103	0	5	20	43
22613	22613 Kells AP, Hadaczek P, Yin DL, Bringas J, Varenika V, et al. Efficient gene therapy-based method for the delivery of therapeutics to primate cortex PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009 FEB 17; 106 (7): 2407-2411	0	13	5	42
22614	22614 Masuda M, Hasegawa M, Nonaka T, Oikawa T, Yonetani M, et al. Inhibition of alpha-synuclein fibril assembly by small molecules: Analysis using epitope-specific antibodies FEBS LETTERS. 2009 FEB 18; 583 (4): 787-791	5	7	20	27
22615	22615 Lu XH, Fleming SM, Meurers B, Ackerson LC, Mortazavi F, et al. Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K- Resistant alpha-Synuclein JOURNAL OF NEUROSCIENCE. 2009 FEB 18; 29 (7): 1962-1976	11	20	45	104
22616	22616 Young JE, Garden GA, Martinez RA, Tanaka F, Sandoval CM, et al. Polyglutamine-Expanded Androgen Receptor Truncation Fragments Activate a Bax-Dependent Apoptotic Cascade Mediated by DP5/Hrk JOURNAL OF NEUROSCIENCE. 2009 FEB 18; 29 (7): 1987-1997	2	5	27	80
22617	22617 Carrettiero DC, Hernandez I, Neveu P, Papagiannakopoulos T, Kosik KS The Cochaperone BAG2 Sweeps Paired Helical Filament-Insoluble Tau from the Microtubule JOURNAL OF NEUROSCIENCE. 2009 FEB 18; 29 (7): 2151-2161	9	15	25	58
22618	22618 Vivacqua G, Yin JJ, Casini A, Li X, Li YH, et al. IMMUNOLOCALIZATION OF ALPHA-SYNUCLEIN IN THE RAT SPINAL CORD BY TWO NOVEL MONOCLONAL ANTIBODIES NEUROSCIENCE. 2009 FEB 18; 158 (4): 1478-1487	0	0	28	51
22619	22619 Huynh THV, Mantel MLH, Mikkelsen K, Lindhardt AT, Nielsen NC, et al. A Versatile Approach to beta-Amyloid Fibril-Binding Compounds Exploiting the Shirakawa/Hayashi Protocol for trans-Alkene Synthesis ORGANIC LETTERS. 2009 FEB 19; 11 (4): 999-1002	1	2	8	21
22620	22620 Piguet O, Hornberger M, Shelley BP, Kipps CM, Hodges JR Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia NEUROLOGY. 2009 FEB 24; 72 (8): 732-737	7	10	12	23
#	Date / Author / Journal	LCS	GCS	LCR	CR
22621	22621 Baulac S, Lu H, Strahle J, Yang T, Goldberg MS, et al. Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains MOLECULAR NEURODEGENERATION. 2009 FEB 25; 4: Art. No. 12	4	5	15	60
22622	22622 Greco SJ, Sarkar S, Johnston JM, Tezapsidis N Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2009 FEB 27; 380 (1): 98-104	3	11	7	37
22623	22623 Gu ST, Huang H, Bi JQ, Yao Y, Wen TQ Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model BRAIN RESEARCH. 2009 FEB 27; 1257: 1-9	0	0	10	38
22624	22624 Mendonsa G, Dobrowolska J, Lin A, Vijairania P, Jong YJI, et al. Molecular Profiling Reveals Diversity of Stress Signal Transduction Cascades in Highly Penetrant Alzheimer's Disease Human Skin Fibroblasts PLOS ONE. 2009 FEB 27; 4 (2): Art. No. e4655	0	2	20	96
22625	22625 Kwiatkowski TJ, Bosco DA, LeClerc AL, Tamrazian E, Vanderburg CR, et al. Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis SCIENCE. 2009 FEB 27; 323 (5918): 1205-1208	133	184	5	22
22626	22626 Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 SCIENCE. 2009 FEB 27; 323 (5918): 1208-1211	131	184	10	27
22627	22627 Santpere G, Ferrer I LRRK2 and neurodegeneration ACTA NEUROPATHOLOGICA. 2009 MAR; 117 (3): 227-246	10	13	37	110
22628	22628 Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium ACTA NEUROPATHOLOGICA. 2009 MAR; 117 (3): 309-320	5	9	17	31
22629	22629 Keene CD, Chang RC, Leverenz JB, Kopyov O, Perlman S, et al. A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions ACTA NEUROPATHOLOGICA. 2009 MAR; 117 (3): 329-338	3	7	8	27
22630	22630 Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, et al. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008 ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 85-92	6	6	0	4
#	Date / Author / Journal	LCS	GCS	LCR	CR
22631	22631 Petersen RC Commentary on "A roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 105-107	0	0	4	12
22632	22632 Simpkins JW, Gatson JW, Wigginton JG Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 143-146	0	0	20	46
22633	22633 Carrillo MC, Blackwell A, Hampel H, Lindborg J, Sperling R, et al. Early risk assessment for Alzheimer's disease ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 182-196	3	5	23	124
22634	22634 Perneczky R, Hausermann P, Drzezga A, Boecker H, Granert O, et al. Fluoro-Deoxy-Glucose Positron Emission Tomography Correlates of Impaired Activities of Daily Living in Dementia With Lewy Bodies: Implications for Cognitive Reserve AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2009 MAR; 17 (3): 188-195	2	8	9	49
22635	22635 Desikan RS, Cabral HJ, Fischl B, Guttmann CRG, Blacker D, et al. Temporoparietal MR Imaging Measures of Atrophy in Subjects with Mild Cognitive Impairment That Predict Subsequent Diagnosis of Alzheimer Disease AMERICAN JOURNAL OF NEURORADIOLOGY. 2009 MAR; 30 (3): 532-538	3	9	5	54
22636	22636 Zou WQ, Gambetti P Variant Creutzfeldt-Jakob Disease: French versus British ANNALS OF NEUROLOGY. 2009 MAR; 65 (3): 233-235	0	0	4	19
22637	22637 Brandel JP, Heath CA, Head MW, Levavasseur E, Knight R, et al. Variant Creutzfeldt-Jakob Disease in France and the United Kingdom: Evidence for the Same Agent Strain ANNALS OF NEUROLOGY. 2009 MAR; 65 (3): 249-256	0	10	7	32
22638	22638 Esteves AR, Arduino DM, Swerdlow RH, Oliveira CR, Cardoso SM Oxidative Stress Involvement in alpha-Synuclein Oligomerization in Parkinson's Disease Cybrids ANTIOXIDANTS & REDOX SIGNALING. 2009 MAR; 11 (3): 439-448	4	10	16	46
22639	22639 Clark J, Simon DK Transcribe to Survive: Transcriptional Control of Antioxidant Defense Programs for Neuroprotection in Parkinson's Disease ANTIOXIDANTS & REDOX SIGNALING. 2009 MAR; 11 (3): 509-528	2	7	26	228
22640	22640 Martinez MC, Andriantsitohaina R Reactive Nitrogen Species: Molecular Mechanisms and Potential Significance in Health and Disease ANTIOXIDANTS & REDOX SIGNALING. 2009 MAR; 11 (3): 669-702	1	8	27	361
#	Date / Author / Journal	LCS	GCS	LCR	CR
22641	22641 Cho HY, Lee M, Takei H, Dancer J, Ro JY, et al. Immunohistochemical Comparison of Chordoma With Chondrosarcoma, Myxopapillary Ependymoma, and Chordoid Meningioma APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY. 2009 MAR; 17 (2): 131-138	0	3	10	34
22642	22642 Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, et al. Cerebrospinal Fluid beta-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain ARCHIVES OF NEUROLOGY. 2009 MAR; 66 (3): 382-389	34	47	11	27
22643	22643 Liscic RM FRONTOTEMPORAL DEMENTIAS: UPDATE ON RECENT DEVELOPMENTS IN MOLECULAR GENETICS AND NEUROPATHOLOGY ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU. 2009 MAR; 60 (1): 117-122	0	0	20	30
22644	22644 Barsottini OGP, Felicio AC, Aguiar PD, Godeiro C, Shih MC, et al. CLINICAL AND MOLECULAR NEUROIMAGING CHARACTERISTICS OF BRAZILIAN PATIENTS WITH PARKINSON'S DISEASE AND MUTATIONS IN PARK2 OR PARK8 GENES ARQUIVOS DE NEURO-PSIQUIATRIA. 2009 MAR; 67 (1): 7-11	0	1	6	21
22645	22645 Morris AM, Watzky MA, Finke RG Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2009 MAR; 1794 (3): 375-397	5	31	19	162
22646	22646 Lee D, Park CW, Paik SR, Choi KY The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2009 MAR; 1794 (3): 421-430	1	2	12	29
22647	22647 Bird TD Progranulin plasma levels in the diagnosis of frontotemporal dementia BRAIN. 2009 MAR; 132: 568-569	0	0	6	11
22648	22648 Finch N, Baker M, Crook R, Swanson K, Kuntz K, et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members BRAIN. 2009 MAR; 132: 583-591	22	30	30	43
22649	22649 Kipps CM, Nestor PJ, Acosta-Cabronero J, Arnold R, Hodges JR Understanding social dysfunction in the behavioural variant of frontotemporal dementia: the role of emotion and sarcasm processing BRAIN. 2009 MAR; 132: 592-603	3	10	19	105
22650	22650 Maalouf M, Rho JM, Mattson MP The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies BRAIN RESEARCH REVIEWS. 2009 MAR; 59 (2): 293-315	0	27	21	376
#	Date / Author / Journal	LCS	GCS	LCR	CR
22651	22651 Arboleda G, Morales LC, Benitez B, Arboleda H Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration BRAIN RESEARCH REVIEWS. 2009 MAR; 59 (2): 333-346	0	8	18	191
22652	22652 Minnikanti S, Skeath P, Peixoto N Electrochemical characterization of multi-walled carbon nanotube coated electrodes for biological applications CARBON. 2009 MAR; 47 (3): 884-893	1	7	1	66
22653	22653 Kondo K, Watanabe K, Sakamoto T, Suzukawa K, Nibu K, et al. Distribution and severity of spontaneous lesions in the neuroepithelium and Bowman's glands in mouse olfactory mucosa: age-related progression CELL AND TISSUE RESEARCH. 2009 MAR; 335 (3): 489-503	1	4	6	57
22654	22654 Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, et al. Stem cell therapy in stroke CELLULAR AND MOLECULAR LIFE SCIENCES. 2009 MAR; 66 (5): 757-772	5	12	18	148
22655	22655 Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, et al. The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals CEREBRAL CORTEX. 2009 MAR; 19 (3): 497-510	19	48	11	85
22656	22656 Morimoto BH, De Lannoy I, Fox AW, Gozes I, Stewart A Davunetide Pharmacokinetics and distribution to brain after intravenous or intranasal administration to rat CHIMICA OGGI-CHEMISTRY TODAY. 2009 MAR-APR; 27 (2): 16-20	1	3	7	19
22657	22657 Andres RH, Guzman R, Weis J, Brekenfeld C, Fandino J, et al. Lhermitte-Duclos disease with atypical vascularization - case report and review of the literature CLINICAL NEUROPATHOLOGY. 2009 MAR-APR; 28 (2): 83-90	0	1	5	73
22658	22658 Deane R, Bell RD, Sagare A, Zlokovic BV Clearance of Amyloid-beta Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2009 MAR; 8 (1): 16-30	5	23	18	139
22659	22659 Golde TE, Das P, Levites Y Quantitative and Mechanistic Studies of A beta Immunotherapy CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2009 MAR; 8 (1): 31-49	2	3	21	107
22660	22660 Lambert MP, Velasco PT, Viola KL, Klein WL Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid beta-Derived Neurotoxins CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2009 MAR; 8 (1): 65-81	5	5	33	122
#	Date / Author / Journal	LCS	GCS	LCR	CR
22661	22661 Thompson JJ, Ritenbaugh C, Nichter M Reconsidering the Placebo Response from a Broad Anthropological Perspective CULTURE MEDICINE AND PSYCHIATRY. 2009 MAR; 33 (1): 112-152	0	5	4	194
22662	22662 George JL, Mok S, Moses D, Wilkins S, Bush AI, et al. Targeting the Progression of Parkinson's Disease CURRENT NEUROPHARMACOLOGY. 2009 MAR; 7 (1): 9-36	2	5	96	454
22663	22663 Schwab SG, Wildenauer DB Update on key previously proposed candidate genes for schizophrenia CURRENT OPINION IN PSYCHIATRY. 2009 MAR; 22 (2): 147-153	0	5	5	76
22664	22664 Chen YC, Cheng CH, Chen GD, Hung CC, Yang CH, et al. Recapitulation of Zebrafish sncga Expression Pattern and Labeling the Habenular Complex in Transgenic Zebrafish Using Green Fluorescent Protein Reporter Gene DEVELOPMENTAL DYNAMICS. 2009 MAR; 238 (3): 746-754	2	3	16	42
22665	22665 Kuai XL, Gagliardi C, Flaat M, Bunnell BA Differentiation of nonhuman primate embryonic stem cells along neural lineages DIFFERENTIATION. 2009 MAR; 77 (3): 229-238	0	1	11	63
22666	22666 Gitler AD Disease models and mechanisms in the classroom DISEASE MODELS & MECHANISMS. 2009 MAR-APR; 2 (3-4): 103-106	0	0	2	15
22667	22667 Wan HI, Hurko O, Day M, Rutkowski JL Translational Medicine Perspective in Development of Disease Modifying Therapies for Alzheimer's Disease: Biomarkers to Buy Down the Risk DRUG DEVELOPMENT RESEARCH. 2009 MAR; 70 (2): 60-69	0	1	18	78
22668	22668 Savage MJ, Gingrich DE Advances in the Development of Kinase Inhibitor Therapeutics for Alzheimer's Disease DRUG DEVELOPMENT RESEARCH. 2009 MAR; 70 (2): 125-144	2	5	78	221
22669	22669 Thompson PW, Lockhart A Monitoring the amyloid beta-peptide in vivo - caveat emptor DRUG DISCOVERY TODAY. 2009 MAR; 14 (5-6): 241-251	1	2	22	87
22670	22670 Canu E, Boccardi M, Ghidoni R, Benussi L, Testa C, et al. H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers EUROPEAN JOURNAL OF HUMAN GENETICS. 2009 MAR; 17 (3): 287-294	0	0	25	57
#	Date / Author / Journal	LCS	GCS	LCR	CR
22671	22671 Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options EUROPEAN JOURNAL OF NEUROLOGY. 2009 MAR; 16 (3): 297-309	11	17	50	84
22672	22672 Marxreiter F, Nuber S, Kandasamy M, Klucken J, Aigner R, et al. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein EUROPEAN JOURNAL OF NEUROSCIENCE. 2009 MAR; 29 (5): 879-890	4	6	17	42
22673	22673 Bellon A, Le Pen G, Matricon J, Jay TM, Krebs MO Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia EXPERT OPINION ON DRUG DISCOVERY. 2009 MAR; 4 (3): 257-278	0	0	30	221
22674	22674 Noble W, Garwood C, Stephenson J, Kinsey AM, Hanger DP, et al. Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease FASEB JOURNAL. 2009 MAR; 23 (3): 739-750	4	15	23	54
22675	22675 Filali M, Lalonde R, Rivest S Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease GENES BRAIN AND BEHAVIOR. 2009 MAR; 8 (2): 143-148	0	8	5	34
22676	22676 Beyer K, Domingo-Sabat M, Ariza A Molecular Pathology of Lewy Body Diseases INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 724-745	6	7	86	145
22677	22677 Olivares D, Huang XD, Branden L, Greig NH, Rogers JT Physiological and Pathological Role of Alpha-synuclein in Parkinson's Disease Through Iron Mediated Oxidative Stress; The Role of a Putative Iron-responsive Element INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 1226-1260	4	11	112	198
22678	22678 Castellani RJ, Zhu XW, Lee HG, Smith MA, Perry G Molecular Pathogenesis of Alzheimer's Disease: Reductionist versus Expansionist Approaches INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 1386-1406	5	12	47	146
22679	22679 Fontana PA, Barbeito CG, Goya RG, Gimeno EJ, Portiansky EL Impact of very old age on the expression of cervical spinal cord cell markers in rats JOURNAL OF CHEMICAL NEUROANATOMY. 2009 MAR; 37 (2): 98-104	0	1	6	26
22680	22680 Xiong H, Wang DL, Chen LN, Choo YS, Ma H, et al. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation JOURNAL OF CLINICAL INVESTIGATION. 2009 MAR; 119 (3): 650-660	15	51	20	47
#	Date / Author / Journal	LCS	GCS	LCR	CR
22681	22681 Lee PH, Park HJ Bone Marrow-Derived Mesenchymal Stem Cell Therapy as a Candidate Disease-Modifying Strategy in Parkinson's Disease and Multiple System Atrophy JOURNAL OF CLINICAL NEUROLOGY. 2009 MAR; 5 (1): 1-10	0	7	20	73
22682	22682 Cho JW, Kim SY, Park SS, Jeon BS The G2019S LRRK2 Mutation is Rare in Korean Patients with Parkinson's Disease and Multiple System Atrophy JOURNAL OF CLINICAL NEUROLOGY. 2009 MAR; 5 (1): 29-32	0	3	12	35
22683	22683 Li LH, Qin HZ, Wang JL, Wang J, Wang XL, et al. Axonal Degeneration of Nigra-striatum Dopaminergic Neurons Induced by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in Mice JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. 2009 MAR-APR; 37 (2): 455-463	0	0	7	15
22684	22684 Trebunova M, Slaba E, Habalova V, Gdovinova Z The role of the-427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia JOURNAL OF NEURAL TRANSMISSION. 2009 MAR; 116 (3): 339-344	0	0	1	25
22685	22685 Stieler JT, Bullmann T, Kohl F, Barnes BM, Arendt T PHF-like tau phosphorylation in mammalian hibernation is not associated with p25-formation JOURNAL OF NEURAL TRANSMISSION. 2009 MAR; 116 (3): 345-350	0	1	19	47
22686	22686 Hanes J, Zilka N, Bartkova M, Caletkova M, Dobrota D, et al. Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (5): 1167-1176	2	4	36	56
22687	22687 Yu Y, Run XQ, Liang ZH, Li Y, Liu F, et al. Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (6): 1480-1494	3	7	33	67
22688	22688 Marongiu R, Spencer B, Crews L, Adame A, Patrick C, et al. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (6): 1561-1574	6	17	44	92
22689	22689 Yu JP, Lyubchenko YL Early Stages for Parkinson's Development: alpha-Synuclein Misfolding and Aggregation JOURNAL OF NEUROIMMUNE PHARMACOLOGY. 2009 MAR; 4 (1): 10-16	2	6	18	43
22690	22690 Meissner B, Kallenberg K, Sanchez-Juan P, Ramljak S, Krasnianski A, et al. MRI and clinical syndrome in dura materrelated Creutzfeldt-Jakob disease JOURNAL OF NEUROLOGY. 2009 MAR; 256 (3): 355-363	0	0	16	60
#	Date / Author / Journal	LCS	GCS	LCR	CR
22691	22691 Lemmens R, Race V, Hersmus N, Matthijs G, Van den Bosch L, et al. TDP-43 M311V mutation in familial amyotrophic lateral sclerosis JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2009 MAR; 80 (3): 354-U135	18	19	4	5
22692	22692 McGinn MJ, Kelley BJ, Akinyi L, Oli MW, Liu MC, et al. Biochemical, Structural, and Biomarker Evidence for Calpain-Mediated Cytoskeletal Change After Diffuse Brain Injury Uncomplicated by Contusion JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 MAR; 68 (3): 241-249	5	13	25	43
22693	22693 Olive M, Janue A, Moreno D, Gamez J, Torrejon-Escribano B, et al. TAR DNA-Binding Protein 43 Accumulation in Protein Aggregate Myopathies JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 MAR; 68 (3): 262-273	8	12	24	68
22694	22694 Gomez A, Ferrer I Increased Oxidation of Certain Glycolysis and Energy Metabolism Enzymes in the Frontal Cortex in Lewy Body Diseases JOURNAL OF NEUROSCIENCE RESEARCH. 2009 MAR; 87 (4): 1002-1013	3	5	21	59
22695	22695 Tractenberg RE ANALYTIC METHODS FOR FACTORS, DIMENSIONS AND ENDPOINTS IN CLINICAL TRIALS FOR ALZHEIMER'S DISEASE JOURNAL OF NUTRITION HEALTH & AGING. 2009 MAR; 13 (3): 249-255	0	1	3	26
22696	22696 Hua H, Xu L, Wang L, Jing J, Luo T, et al. Up-regulation of gamma-synuclein contributes to cancer cell survival under endoplasmic reticulum stress JOURNAL OF PATHOLOGY. 2009 MAR; 217 (4): 507-515	1	1	17	50
22697	22697 Yang LL, Ha JR, Zhang J, Xia WJ, Dong XF, et al. Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin JOURNAL OF PHARMACY AND PHARMACOLOGY. 2009 MAR; 61 (3): 375-380	1	4	4	37
22698	22698 Tate CC, Shear DA, Tate MC, Archer DR, Stein DG, et al. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE. 2009 MAR; 3 (3): 208-217	1	6	10	40
22699	22699 Hankins D, Chao S, Dolmatch BL, Jeyarajah RD Covered Stents for Late Postoperative Arterial Hemorrhage after Pancreaticoduodenectomy JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 2009 MAR; 20 (3): 407-409	0	0	1	14
22700	22700 Williams DR, Lees AJ Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges LANCET NEUROLOGY. 2009 MAR; 8 (3): 270-279	15	30	29	104

Date / Author / Journal

LCS

GCS

LCR

2009

22601

22601 Lu YM, Ansar S, Michaelis ML, Blagg BSJ

Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line

BIOORGANIC & MEDICINAL CHEMISTRY. 2009 FEB 15; 17 (4): 1709-1715

22602

22602 Jacobs FMJ, van Erp S, van der Linden AJA, von Oerthel L, Burbach JPH, et al.

Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression

DEVELOPMENT. 2009 FEB 15; 136 (4): 531-540

22603

22603 Sato T, Miura M, Yamada M, Yoshida T, Wood JD, et al.

Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice

HUMAN MOLECULAR GENETICS. 2009 FEB 15; 18 (4): 723-736

22604

22604 Rohrer JD, Rossor MN, Warren JD

Neologistic jargon aphasia and agraphia in primary progressive aphasia

JOURNAL OF THE NEUROLOGICAL SCIENCES. 2009 FEB 15; 277 (1-2): 155-159

22605

22605 Olanow CW, Gracies JM, Goetz CG, Stoessl AJ, Freeman T, et al.

Clinical Pattern and Risk Factors for Dyskinesias Following Fetal Nigral Transplantation in Parkinson's Disease: A Double Blind Video- Based Analysis

MOVEMENT DISORDERS. 2009 FEB 15; 24 (3): 336-343

22606

22606 Edler J, Mollenhauer B, Heinemann U, Varges D, Werner C, et al.

Movement Disturbances in the Differential Diagnosis of Creutzfeldt- Jakob Disease

MOVEMENT DISORDERS. 2009 FEB 15; 24 (3): 350-356

22607

22607 Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, et al.

FGF20 and Parkinson's Disease: No Evidence of Association or Pathogenicity via alpha-Synuclein Expression

MOVEMENT DISORDERS. 2009 FEB 15; 24 (3): 455-459

22608

22608 Salat DH, Greve DN, Pacheco JL, Quinn BT, Helmer KG, et al.

Regional white matter volume differences in nondemented aging and Alzheimer's disease

NEUROIMAGE. 2009 FEB 15; 44 (4): 1247-1258

22609

22609 Brooks D, Halliday GM

Intralaminar nuclei of the thalamus in Lewy body diseases

BRAIN RESEARCH BULLETIN. 2009 FEB 16; 78 (2-3): 97-104

22610

22610 Kassiou M, Banati R, Holsinger RMD, Meikle S

Challenges in molecular imaging of Parkinson's disease: A brief overview

BRAIN RESEARCH BULLETIN. 2009 FEB 16; 78 (2-3): 105-108

Date / Author / Journal

22611

"Disease-modification" trials in Parkinson disease: Target populations, endpoints and study design

NEUROLOGY. 2009 FEB 17; 72: S51-S58

22612

22612 Chu J, Hong NA, Masuda CA, Jenkins BV, Nelms KA, et al.

A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009 FEB 17; 106 (7): 2097-2103

22613

22613 Kells AP, Hadaczek P, Yin DL, Bringas J, Varenika V, et al.

Efficient gene therapy-based method for the delivery of therapeutics to primate cortex

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009 FEB 17; 106 (7): 2407-2411

22614

22614 Masuda M, Hasegawa M, Nonaka T, Oikawa T, Yonetani M, et al.

Inhibition of alpha-synuclein fibril assembly by small molecules: Analysis using epitope-specific antibodies

FEBS LETTERS. 2009 FEB 18; 583 (4): 787-791

22615

22615 Lu XH, Fleming SM, Meurers B, Ackerson LC, Mortazavi F, et al.JOURNAL OF NEUROSCIENCE. 2009 FEB 18; 29 (7): 1962-1976

104

22616

22616 Young JE, Garden GA, Martinez RA, Tanaka F, Sandoval CM, et al.

Polyglutamine-Expanded Androgen Receptor Truncation Fragments Activate a Bax-Dependent Apoptotic Cascade Mediated by DP5/Hrk

JOURNAL OF NEUROSCIENCE. 2009 FEB 18; 29 (7): 1987-1997

22617

22617 Carrettiero DC, Hernandez I, Neveu P, Papagiannakopoulos T, Kosik KS

The Cochaperone BAG2 Sweeps Paired Helical Filament-Insoluble Tau from the Microtubule

JOURNAL OF NEUROSCIENCE. 2009 FEB 18; 29 (7): 2151-2161

22618

22618 Vivacqua G, Yin JJ, Casini A, Li X, Li YH, et al.

IMMUNOLOCALIZATION OF ALPHA-SYNUCLEIN IN THE RAT SPINAL CORD BY TWO NOVEL MONOCLONAL ANTIBODIES

NEUROSCIENCE. 2009 FEB 18; 158 (4): 1478-1487

22619

22619 Huynh THV, Mantel MLH, Mikkelsen K, Lindhardt AT, Nielsen NC, et al.

A Versatile Approach to beta-Amyloid Fibril-Binding Compounds Exploiting the Shirakawa/Hayashi Protocol for trans-Alkene Synthesis

ORGANIC LETTERS. 2009 FEB 19; 11 (4): 999-1002

22620

22620 Piguet O, Hornberger M, Shelley BP, Kipps CM, Hodges JR

Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia

NEUROLOGY. 2009 FEB 24; 72 (8): 732-737

Date / Author / Journal

LCS

GCS

LCR

22621

22621 Baulac S, Lu H, Strahle J, Yang T, Goldberg MS, et al.

Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains

MOLECULAR NEURODEGENERATION. 2009 FEB 25; 4: Art. No. 12

22622

22622 Greco SJ, Sarkar S, Johnston JM, Tezapsidis N

Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2009 FEB 27; 380 (1): 98-104

22623

22623 Gu ST, Huang H, Bi JQ, Yao Y, Wen TQ

Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model

BRAIN RESEARCH. 2009 FEB 27; 1257: 1-9

22624

22624 Mendonsa G, Dobrowolska J, Lin A, Vijairania P, Jong YJI, et al.

Molecular Profiling Reveals Diversity of Stress Signal Transduction Cascades in Highly Penetrant Alzheimer's Disease Human Skin Fibroblasts

PLOS ONE. 2009 FEB 27; 4 (2): Art. No. e4655

22625

22625 Kwiatkowski TJ, Bosco DA, LeClerc AL, Tamrazian E, Vanderburg CR, et al.

Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis

SCIENCE. 2009 FEB 27; 323 (5918): 1205-1208

133

184

22626

22626 Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, et al.

Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6

SCIENCE. 2009 FEB 27; 323 (5918): 1208-1211

131

184

22627

22627 Santpere G, Ferrer I

LRRK2 and neurodegeneration

ACTA NEUROPATHOLOGICA. 2009 MAR; 117 (3): 227-246

110

22628

22628 Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, et al.

Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium

ACTA NEUROPATHOLOGICA. 2009 MAR; 117 (3): 309-320

22629

22629 Keene CD, Chang RC, Leverenz JB, Kopyov O, Perlman S, et al.

A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions

ACTA NEUROPATHOLOGICA. 2009 MAR; 117 (3): 329-338

22630

22630 Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, et al.

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008

ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 85-92

Date / Author / Journal

22631

Commentary on "A roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging

ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 105-107

22632

22632 Simpkins JW, Gatson JW, Wigginton JG

Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients

ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 143-146

22633

22633 Carrillo MC, Blackwell A, Hampel H, Lindborg J, Sperling R, et al.

Early risk assessment for Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2009 MAR; 5 (2): 182-196

124

22634

22634 Perneczky R, Hausermann P, Drzezga A, Boecker H, Granert O, et al.

Fluoro-Deoxy-Glucose Positron Emission Tomography Correlates of Impaired Activities of Daily Living in Dementia With Lewy Bodies: Implications for Cognitive Reserve

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2009 MAR; 17 (3): 188-195

22635

22635 Desikan RS, Cabral HJ, Fischl B, Guttmann CRG, Blacker D, et al.

Temporoparietal MR Imaging Measures of Atrophy in Subjects with Mild Cognitive Impairment That Predict Subsequent Diagnosis of Alzheimer Disease

AMERICAN JOURNAL OF NEURORADIOLOGY. 2009 MAR; 30 (3): 532-538

22636

22636 Zou WQ, Gambetti P

Variant Creutzfeldt-Jakob Disease: French versus British

ANNALS OF NEUROLOGY. 2009 MAR; 65 (3): 233-235

22637

22637 Brandel JP, Heath CA, Head MW, Levavasseur E, Knight R, et al.

Variant Creutzfeldt-Jakob Disease in France and the United Kingdom: Evidence for the Same Agent Strain

ANNALS OF NEUROLOGY. 2009 MAR; 65 (3): 249-256

22638

22638 Esteves AR, Arduino DM, Swerdlow RH, Oliveira CR, Cardoso SM

Oxidative Stress Involvement in alpha-Synuclein Oligomerization in Parkinson's Disease Cybrids

ANTIOXIDANTS & REDOX SIGNALING. 2009 MAR; 11 (3): 439-448

22639

22639 Clark J, Simon DK

Transcribe to Survive: Transcriptional Control of Antioxidant Defense Programs for Neuroprotection in Parkinson's Disease

ANTIOXIDANTS & REDOX SIGNALING. 2009 MAR; 11 (3): 509-528

228

22640

22640 Martinez MC, Andriantsitohaina R

Reactive Nitrogen Species: Molecular Mechanisms and Potential Significance in Health and Disease

ANTIOXIDANTS & REDOX SIGNALING. 2009 MAR; 11 (3): 669-702

361

Date / Author / Journal

LCS

GCS

LCR

22641

22641 Cho HY, Lee M, Takei H, Dancer J, Ro JY, et al.

Immunohistochemical Comparison of Chordoma With Chondrosarcoma, Myxopapillary Ependymoma, and Chordoid Meningioma

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY. 2009 MAR; 17 (2): 131-138

22642

22642 Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, et al.

Cerebrospinal Fluid beta-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

ARCHIVES OF NEUROLOGY. 2009 MAR; 66 (3): 382-389

22643

22643 Liscic RM

FRONTOTEMPORAL DEMENTIAS: UPDATE ON RECENT DEVELOPMENTS IN MOLECULAR GENETICS AND NEUROPATHOLOGY

ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU. 2009 MAR; 60 (1): 117-122

22644

22644 Barsottini OGP, Felicio AC, Aguiar PD, Godeiro C, Shih MC, et al.

CLINICAL AND MOLECULAR NEUROIMAGING CHARACTERISTICS OF BRAZILIAN PATIENTS WITH PARKINSON'S DISEASE AND MUTATIONS IN PARK2 OR PARK8 GENES

ARQUIVOS DE NEURO-PSIQUIATRIA. 2009 MAR; 67 (1): 7-11

22645

22645 Morris AM, Watzky MA, Finke RG

Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2009 MAR; 1794 (3): 375-397

162

22646

22646 Lee D, Park CW, Paik SR, Choi KY

The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2009 MAR; 1794 (3): 421-430

22647

22647 Bird TD

Progranulin plasma levels in the diagnosis of frontotemporal dementia

BRAIN. 2009 MAR; 132: 568-569

22648

22648 Finch N, Baker M, Crook R, Swanson K, Kuntz K, et al.

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

BRAIN. 2009 MAR; 132: 583-591

22649

22649 Kipps CM, Nestor PJ, Acosta-Cabronero J, Arnold R, Hodges JR

Understanding social dysfunction in the behavioural variant of frontotemporal dementia: the role of emotion and sarcasm processing

BRAIN. 2009 MAR; 132: 592-603

105

22650

22650 Maalouf M, Rho JM, Mattson MP

The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies

BRAIN RESEARCH REVIEWS. 2009 MAR; 59 (2): 293-315

376

Date / Author / Journal

LCS

GCS

LCR

22651

22651 Arboleda G, Morales LC, Benitez B, Arboleda H

Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration

BRAIN RESEARCH REVIEWS. 2009 MAR; 59 (2): 333-346

191

22652

22652 Minnikanti S, Skeath P, Peixoto N

Electrochemical characterization of multi-walled carbon nanotube coated electrodes for biological applications

CARBON. 2009 MAR; 47 (3): 884-893

22653

22653 Kondo K, Watanabe K, Sakamoto T, Suzukawa K, Nibu K, et al.

Distribution and severity of spontaneous lesions in the neuroepithelium and Bowman's glands in mouse olfactory mucosa: age-related progression

CELL AND TISSUE RESEARCH. 2009 MAR; 335 (3): 489-503

22654

22654 Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, et al.

Stem cell therapy in stroke

CELLULAR AND MOLECULAR LIFE SCIENCES. 2009 MAR; 66 (5): 757-772

148

22655

22655 Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, et al.

The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals

CEREBRAL CORTEX. 2009 MAR; 19 (3): 497-510

22656

22656 Morimoto BH, De Lannoy I, Fox AW, Gozes I, Stewart A

Davunetide Pharmacokinetics and distribution to brain after intravenous or intranasal administration to rat

CHIMICA OGGI-CHEMISTRY TODAY. 2009 MAR-APR; 27 (2): 16-20

22657

22657 Andres RH, Guzman R, Weis J, Brekenfeld C, Fandino J, et al.

Lhermitte-Duclos disease with atypical vascularization - case report and review of the literature

CLINICAL NEUROPATHOLOGY. 2009 MAR-APR; 28 (2): 83-90

22658

22658 Deane R, Bell RD, Sagare A, Zlokovic BV

Clearance of Amyloid-beta Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2009 MAR; 8 (1): 16-30

139

22659

22659 Golde TE, Das P, Levites Y

Quantitative and Mechanistic Studies of A beta Immunotherapy

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2009 MAR; 8 (1): 31-49

107

22660

22660 Lambert MP, Velasco PT, Viola KL, Klein WL

Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid beta-Derived Neurotoxins

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2009 MAR; 8 (1): 65-81

122

Date / Author / Journal

LCS

GCS

LCR

22661

22661 Thompson JJ, Ritenbaugh C, Nichter M

Reconsidering the Placebo Response from a Broad Anthropological Perspective

CULTURE MEDICINE AND PSYCHIATRY. 2009 MAR; 33 (1): 112-152

194

22662

22662 George JL, Mok S, Moses D, Wilkins S, Bush AI, et al.

Targeting the Progression of Parkinson's Disease

CURRENT NEUROPHARMACOLOGY. 2009 MAR; 7 (1): 9-36

454

22663

22663 Schwab SG, Wildenauer DB

Update on key previously proposed candidate genes for schizophrenia

CURRENT OPINION IN PSYCHIATRY. 2009 MAR; 22 (2): 147-153

22664

22664 Chen YC, Cheng CH, Chen GD, Hung CC, Yang CH, et al.

Recapitulation of Zebrafish sncga Expression Pattern and Labeling the Habenular Complex in Transgenic Zebrafish Using Green Fluorescent Protein Reporter Gene

DEVELOPMENTAL DYNAMICS. 2009 MAR; 238 (3): 746-754

22665

22665 Kuai XL, Gagliardi C, Flaat M, Bunnell BA

Differentiation of nonhuman primate embryonic stem cells along neural lineages

DIFFERENTIATION. 2009 MAR; 77 (3): 229-238

22666

22666 Gitler AD

Disease models and mechanisms in the classroom

DISEASE MODELS & MECHANISMS. 2009 MAR-APR; 2 (3-4): 103-106

22667

22667 Wan HI, Hurko O, Day M, Rutkowski JL

Translational Medicine Perspective in Development of Disease Modifying Therapies for Alzheimer's Disease: Biomarkers to Buy Down the Risk

DRUG DEVELOPMENT RESEARCH. 2009 MAR; 70 (2): 60-69

22668

22668 Savage MJ, Gingrich DE

Advances in the Development of Kinase Inhibitor Therapeutics for Alzheimer's Disease

DRUG DEVELOPMENT RESEARCH. 2009 MAR; 70 (2): 125-144

221

22669

22669 Thompson PW, Lockhart A

Monitoring the amyloid beta-peptide in vivo - caveat emptor

DRUG DISCOVERY TODAY. 2009 MAR; 14 (5-6): 241-251

22670

22670 Canu E, Boccardi M, Ghidoni R, Benussi L, Testa C, et al.

H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers

EUROPEAN JOURNAL OF HUMAN GENETICS. 2009 MAR; 17 (3): 287-294

Date / Author / Journal

LCS

GCS

LCR

22671

22671 Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, et al.

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options

EUROPEAN JOURNAL OF NEUROLOGY. 2009 MAR; 16 (3): 297-309

22672

22672 Marxreiter F, Nuber S, Kandasamy M, Klucken J, Aigner R, et al.

Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein

EUROPEAN JOURNAL OF NEUROSCIENCE. 2009 MAR; 29 (5): 879-890

22673

22673 Bellon A, Le Pen G, Matricon J, Jay TM, Krebs MO

Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia

EXPERT OPINION ON DRUG DISCOVERY. 2009 MAR; 4 (3): 257-278

221

22674

22674 Noble W, Garwood C, Stephenson J, Kinsey AM, Hanger DP, et al.

Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease

FASEB JOURNAL. 2009 MAR; 23 (3): 739-750

22675

22675 Filali M, Lalonde R, Rivest S

Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease

GENES BRAIN AND BEHAVIOR. 2009 MAR; 8 (2): 143-148

22676

22676 Beyer K, Domingo-Sabat M, Ariza A

Molecular Pathology of Lewy Body Diseases

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 724-745

145

22677

22677 Olivares D, Huang XD, Branden L, Greig NH, Rogers JT

Physiological and Pathological Role of Alpha-synuclein in Parkinson's Disease Through Iron Mediated Oxidative Stress; The Role of a Putative Iron-responsive Element

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 1226-1260

112

198

22678

22678 Castellani RJ, Zhu XW, Lee HG, Smith MA, Perry G

Molecular Pathogenesis of Alzheimer's Disease: Reductionist versus Expansionist Approaches

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 1386-1406

146

22679

22679 Fontana PA, Barbeito CG, Goya RG, Gimeno EJ, Portiansky EL

Impact of very old age on the expression of cervical spinal cord cell markers in rats

JOURNAL OF CHEMICAL NEUROANATOMY. 2009 MAR; 37 (2): 98-104

22680

22680 Xiong H, Wang DL, Chen LN, Choo YS, Ma H, et al.

Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation

JOURNAL OF CLINICAL INVESTIGATION. 2009 MAR; 119 (3): 650-660

Date / Author / Journal

LCS

GCS

LCR

22681

22681 Lee PH, Park HJ

Bone Marrow-Derived Mesenchymal Stem Cell Therapy as a Candidate Disease-Modifying Strategy in Parkinson's Disease and Multiple System Atrophy

JOURNAL OF CLINICAL NEUROLOGY. 2009 MAR; 5 (1): 1-10

22682

22682 Cho JW, Kim SY, Park SS, Jeon BS

The G2019S LRRK2 Mutation is Rare in Korean Patients with Parkinson's Disease and Multiple System Atrophy

JOURNAL OF CLINICAL NEUROLOGY. 2009 MAR; 5 (1): 29-32

22683

22683 Li LH, Qin HZ, Wang JL, Wang J, Wang XL, et al.

Axonal Degeneration of Nigra-striatum Dopaminergic Neurons Induced by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in Mice

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. 2009 MAR-APR; 37 (2): 455-463

22684

22684 Trebunova M, Slaba E, Habalova V, Gdovinova Z

The role of the-427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia

JOURNAL OF NEURAL TRANSMISSION. 2009 MAR; 116 (3): 339-344

22685

22685 Stieler JT, Bullmann T, Kohl F, Barnes BM, Arendt T

PHF-like tau phosphorylation in mammalian hibernation is not associated with p25-formation

JOURNAL OF NEURAL TRANSMISSION. 2009 MAR; 116 (3): 345-350

22686

22686 Hanes J, Zilka N, Bartkova M, Caletkova M, Dobrota D, et al.

Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies

JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (5): 1167-1176

22687

22687 Yu Y, Run XQ, Liang ZH, Li Y, Liu F, et al.

Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases

JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (6): 1480-1494

22688

22688 Marongiu R, Spencer B, Crews L, Adame A, Patrick C, et al.

Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux

JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (6): 1561-1574

22689

22689 Yu JP, Lyubchenko YL

Early Stages for Parkinson's Development: alpha-Synuclein Misfolding and Aggregation

JOURNAL OF NEUROIMMUNE PHARMACOLOGY. 2009 MAR; 4 (1): 10-16

22690

22690 Meissner B, Kallenberg K, Sanchez-Juan P, Ramljak S, Krasnianski A, et al.

MRI and clinical syndrome in dura materrelated Creutzfeldt-Jakob disease

JOURNAL OF NEUROLOGY. 2009 MAR; 256 (3): 355-363

Date / Author / Journal

LCS

GCS

LCR

22691

22691 Lemmens R, Race V, Hersmus N, Matthijs G, Van den Bosch L, et al.

TDP-43 M311V mutation in familial amyotrophic lateral sclerosis

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2009 MAR; 80 (3): 354-U135

22692

22692 McGinn MJ, Kelley BJ, Akinyi L, Oli MW, Liu MC, et al.

Biochemical, Structural, and Biomarker Evidence for Calpain-Mediated Cytoskeletal Change After Diffuse Brain Injury Uncomplicated by Contusion

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 MAR; 68 (3): 241-249

22693

22693 Olive M, Janue A, Moreno D, Gamez J, Torrejon-Escribano B, et al.

TAR DNA-Binding Protein 43 Accumulation in Protein Aggregate Myopathies

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 MAR; 68 (3): 262-273

22694

22694 Gomez A, Ferrer I

Increased Oxidation of Certain Glycolysis and Energy Metabolism Enzymes in the Frontal Cortex in Lewy Body Diseases

JOURNAL OF NEUROSCIENCE RESEARCH. 2009 MAR; 87 (4): 1002-1013

22695

22695 Tractenberg RE

ANALYTIC METHODS FOR FACTORS, DIMENSIONS AND ENDPOINTS IN CLINICAL TRIALS FOR ALZHEIMER'S DISEASE

JOURNAL OF NUTRITION HEALTH & AGING. 2009 MAR; 13 (3): 249-255

22696

22696 Hua H, Xu L, Wang L, Jing J, Luo T, et al.

Up-regulation of gamma-synuclein contributes to cancer cell survival under endoplasmic reticulum stress

JOURNAL OF PATHOLOGY. 2009 MAR; 217 (4): 507-515

22697

22697 Yang LL, Ha JR, Zhang J, Xia WJ, Dong XF, et al.

Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin

JOURNAL OF PHARMACY AND PHARMACOLOGY. 2009 MAR; 61 (3): 375-380

22698

22698 Tate CC, Shear DA, Tate MC, Archer DR, Stein DG, et al.

Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain

JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE. 2009 MAR; 3 (3): 208-217

22699

22699 Hankins D, Chao S, Dolmatch BL, Jeyarajah RD

Covered Stents for Late Postoperative Arterial Hemorrhage after Pancreaticoduodenectomy

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 2009 MAR; 20 (3): 407-409

22700

22700 Williams DR, Lees AJ

Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges

LANCET NEUROLOGY. 2009 MAR; 8 (3): 270-279

104

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records